816 related articles for article (PubMed ID: 25001465)
1. Therapeutic vaccines for cancer: an overview of clinical trials.
Melero I; Gaudernack G; Gerritsen W; Huber C; Parmiani G; Scholl S; Thatcher N; Wagstaff J; Zielinski C; Faulkner I; Mellstedt H
Nat Rev Clin Oncol; 2014 Sep; 11(9):509-24. PubMed ID: 25001465
[TBL] [Abstract][Full Text] [Related]
2. Vaccines for immunotherapy of breast cancer and prostate cancer: new developments and comparative aspects.
Minev BR; Guo F; Gueorguieva I; Kaiser HE
In Vivo; 2002; 16(6):405-15. PubMed ID: 12494883
[TBL] [Abstract][Full Text] [Related]
3. Cellular vaccine therapies for cancer.
Mastrangelo MJ; Sato T; Lattime EC; Maguire HC; Berd D
Cancer Treat Res; 1998; 94():35-50. PubMed ID: 9587681
[No Abstract] [Full Text] [Related]
4. Prediction of response to anticancer immunotherapy using gene signatures.
Wang E; Bedognetti D; Marincola FM
J Clin Oncol; 2013 Jul; 31(19):2369-71. PubMed ID: 23715576
[No Abstract] [Full Text] [Related]
5. Active specific immunotherapy: using tumor heterogeneity to successfully fight cancer.
Hanna MG; Howard J; Vermorken J
Hum Vaccin Immunother; 2014; 10(11):3286-96. PubMed ID: 25483649
[No Abstract] [Full Text] [Related]
6. Cancer vaccines.
Butterfield LH
BMJ; 2015 Apr; 350():h988. PubMed ID: 25904595
[TBL] [Abstract][Full Text] [Related]
7. Update on active specific immunotherapy with melanoma vaccines.
Conforti AM; Ollila DW; Kelley MC; Gammon G; Morton DL
J Surg Oncol; 1997 Sep; 66(1):55-64. PubMed ID: 9290695
[TBL] [Abstract][Full Text] [Related]
8. Cancer vaccines: a critical review on clinical impact.
Bitton RJ
Curr Opin Mol Ther; 2004 Feb; 6(1):17-26. PubMed ID: 15011777
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant immunotherapy for solid tumors: from promise to clinical application.
Mocellin S; Rossi CR; Lise M; Marincola FM
Cancer Immunol Immunother; 2002 Dec; 51(11-12):583-95. PubMed ID: 12439603
[TBL] [Abstract][Full Text] [Related]
10. Clinical applications of dendritic cell vaccines.
Morse MA; Lyerly HK
Curr Opin Mol Ther; 2000 Feb; 2(1):20-8. PubMed ID: 11249649
[TBL] [Abstract][Full Text] [Related]
11. Predictive gene signature in MAGE-A3 antigen-specific cancer immunotherapy.
Ulloa-Montoya F; Louahed J; Dizier B; Gruselle O; Spiessens B; Lehmann FF; Suciu S; Kruit WH; Eggermont AM; Vansteenkiste J; Brichard VG
J Clin Oncol; 2013 Jul; 31(19):2388-95. PubMed ID: 23715562
[TBL] [Abstract][Full Text] [Related]
12. Cancer vaccines targeting the HER2/neu oncogenic protein.
Disis ML; Schiffman K
Semin Oncol; 2001 Dec; 28(6 Suppl 18):12-20. PubMed ID: 11774201
[TBL] [Abstract][Full Text] [Related]
13. Vaccination of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigens in combination with interleukin-2: a phase 1 study.
Oosterwijk-Wakka JC; Tiemessen DM; Bleumer I; de Vries IJ; Jongmans W; Adema GJ; Debruyne FM; de Mulder PH; Oosterwijk E; Mulders PF
J Immunother; 2002; 25(6):500-8. PubMed ID: 12439347
[TBL] [Abstract][Full Text] [Related]
14. Tumor-specific antigens and immunologic adjuvants in cancer immunotherapy.
Seremet T; Brasseur F; Coulie PG
Cancer J; 2011; 17(5):325-30. PubMed ID: 21952282
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapies in Early and Advanced Renal Cell Cancer.
Kasenda B; Larkin J; Gore M
Prog Tumor Res; 2015; 42():1-10. PubMed ID: 26376844
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer vaccines: Tumor-associated antigens
Wagner S; Mullins CS; Linnebacher M
World J Gastroenterol; 2018 Dec; 24(48):5418-5432. PubMed ID: 30622371
[TBL] [Abstract][Full Text] [Related]
17. Active and passive immunotherapy: vaccines and antibodies.
Oosterwijk E; Divgi C; Bander NH
BJU Int; 2007 May; 99(5 Pt B):1301-4. PubMed ID: 17441928
[No Abstract] [Full Text] [Related]
18. Advances in Cancer Vaccine Research.
Liu N; Xiao X; Zhang Z; Mao C; Wan M; Shen J
ACS Biomater Sci Eng; 2023 Nov; 9(11):5999-6023. PubMed ID: 37921277
[TBL] [Abstract][Full Text] [Related]
19. Cancer vaccines.
Pardoll DM
Trends Pharmacol Sci; 1993 May; 14(5):202-8. PubMed ID: 8212317
[TBL] [Abstract][Full Text] [Related]
20. Phase II oncology trials: let's be positive.
Ratain MJ
Clin Cancer Res; 2005 Aug; 11(16):5661-2. PubMed ID: 16115898
[No Abstract] [Full Text] [Related]
[Next] [New Search]
